Market revenue in 2023 | USD 3,583.9 million |
Market revenue in 2030 | USD 8,471.6 million |
Growth rate | 13.1% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 62.88% in 2023. Horizon Databook has segmented the Canada non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
According to Global News, nearly one in every five women in Canada is dissatisfied with her appearance. High healthcare expenditure and presence of advanced healthcare facilities are some of the key factors fueling the growth of non-invasive aesthetic treatment market in Canada.
The proposed guidelines classify medical spas on the basis of procedures performed into three categories: Echelon I spas, Echelon II spas, and Echelon III spas. This helps regulate procedures performed in these spas. Moreover, CAMACS aids in normalizing regulations as per the Canadian Standards.
Currently, there are more than 30 approved dermal fillers with Hyaluronic Acid (HA) in the Canadian market. In January 2017, Galderma Canada, Inc., a Canadian dermatology company, launched Restylane Refyne and Restylane Defyne next-generation HA dermal fillers intended for moderate to severe facial wrinkles and folds (nasolabial folds) treatment in Canada.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into Canada non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account